highlight / actuality
Researchers in our laboratory, in collaboration with a Brazilian team at the Oswaldo Cruz Institute (Rio de Janeiro), have identified and described the essential role played by a growth factor, TGFß, in the progression of Chagas disease.
 Waghabi MC, Keramidas M, Bailly S, Degrave W, Mendonça-Lima L, Soeiro MNC, Meirelles MNL, Paciornik S, Araœjo-Jorge TC and Feige JJ
Uptake of host cell Transforming Growth Factor-ß by Trypanosoma cruzi amastigotes in cardiomyocytes. Potential role in parasite cycle completion.
American Journal of Pathology, 2005
 Waghabi MC, Keramidas M, Feige JJ, Araujo-Jorge TC and Bailly S
Activation of transforming growth factor beta by Trypanosoma cruzi.
Cellular Microbiology, 2005
 Araujo-Jorge TC, Waghabi MC, Hasslocher-Moreno AM, Xavier SS, Higuchi Mde L, Keramidas M, Bailly S and Feige JJ
Implication of transforming growth factor-ß1 in Chagas disease myocardiopathy.
The Journal of Infectious Diseases, 2002
 Waghabi MC, Coutinho CM, Soeiro MN, Pereira MC, Feige JJ, Keramidas M, Cosson A, Minoprio P, Van Leuven F and Araujo-Jorge TC
Increased Trypanosoma cruzi invasion and heart fibrosis associated with high transforming growth factor beta levels in mice deficient in α(2)-macroglobulin.
Infection and Immunity, 2002
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.